Conditions: Multiple Myeloma
Keywords: multiple myeloma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 8
Healthy volunteers: no

Brief summary:
To evaluate the effect of VELCADE on platelet aggregation at baseline, 24 hours and 48 hours after infusion in patients with multiple myeloma

Detailed description:

Arms:
arm 1: All participants enrolled

Interventions: intervention 1: Velcade
Intervention descriptions: intervention 1: Single dose of Velcade (1.0-1.3 mg/m2 dose)

Protocol document: